|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
90
|
|
pubmed:dateCreated |
2009-7-7
|
|
pubmed:abstractText |
Lentinan (LNT), a purified beta-glucan, is a biological and immunological modifier and has been used as an anticancer drug in combination with 5-fluorouracil for gastric cancer in Japan. In this prospective randomized study, we evaluated the effects of LNT combination with regard to quality of life (QOL) and LNT binding ratio in monocytes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
pubmed-author:HirataYoshikazuY,
pubmed-author:IkaiMasahiroM,
pubmed-author:ItohSachieS,
pubmed-author:JohTakashiT,
pubmed-author:KataokaHiromiH,
pubmed-author:KawaiTakashiT,
pubmed-author:KubotaEijiE,
pubmed-author:MizoshitaTsutomuT,
pubmed-author:MizushimaTakashiT,
pubmed-author:MochizukiHisatoH,
pubmed-author:MoriYoshinoriY,
pubmed-author:OgasawaraNaotakaN,
pubmed-author:SanoHitoshiH,
pubmed-author:SasakiMakotoM,
pubmed-author:SenoKyojiK,
pubmed-author:ShimuraTakayaT,
pubmed-author:TanidaSatoshiS,
pubmed-author:TogawaShozoS,
pubmed-author:WadaTsuneyaT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
547-50
|
|
pubmed:meshHeading |
pubmed-meshheading:19579640-Adenocarcinoma,
pubmed-meshheading:19579640-Analysis of Variance,
pubmed-meshheading:19579640-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19579640-Drug Combinations,
pubmed-meshheading:19579640-Female,
pubmed-meshheading:19579640-Humans,
pubmed-meshheading:19579640-Lentinan,
pubmed-meshheading:19579640-Male,
pubmed-meshheading:19579640-Oxonic Acid,
pubmed-meshheading:19579640-Paclitaxel,
pubmed-meshheading:19579640-Prospective Studies,
pubmed-meshheading:19579640-Quality of Life,
pubmed-meshheading:19579640-Questionnaires,
pubmed-meshheading:19579640-Stomach Neoplasms,
pubmed-meshheading:19579640-Survival Rate,
pubmed-meshheading:19579640-Tegafur,
pubmed-meshheading:19579640-Treatment Outcome,
pubmed-meshheading:19579640-Tumor Markers, Biological
|
|
pubmed:articleTitle |
Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
|
|
pubmed:affiliation |
Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan. hkataoka@med.nagoya-cu.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
